Richards: Gender, ethics matter in negotiations
By Judith Richards Ten years ago, I began incorporating a videotaped role-playing, coalition bargaining exercise into the negotiation and conflict management class I developed for the California Lutheran University MBA program. The simulation gives students an opportunity to practice using persuasion, collaboration and conflict resolution skills to overcome a competitive scenario. Examining how these simulations Read More →
Our view: Measure Y bond funding critical for Allan Hancock College
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Hitching Post Wines in Buellton opens tasting room
The Hitching Post II restaurant in Buellton enjoyed some high-profile exposure in the 2004 movie “Sideways.” A scene early in the film shows aspiring author Miles and his pal Jack walking along Highway 246 and up to the restaurant, where the roadside Hitching Post sign glows brightly in the twilight. They sit down at the Read More →
Dubroff: Lopker’s entrepreneurial vision created South Coast legacy
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Karl Lopker, founder of Deckers and CEO of QAD, dies at 66
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Europeans OK expanded use of Amgen’s Blincyto
The European Commission approved an expanded use for Amgen’s leukemia therapy Blincyto in treating pediatric patients Aug. 29. Based on results from a study of 93 pediatric patients, the approval allows its use in patients a year old or older with a particular type of relapsed or refractory acute lymphoblastic leukemia. “Historically, children with relapsed Read More →
Semtech doubles net income
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
